Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

December 2, 2022

View Archives Issues

  • Updates on the Management of Pediatric Fevers in Patients 4–12 Weeks of Age

    Historically, all febrile infants younger than 90 days of age were aggressively evaluated and treated with empiric antibiotics until culture results were available. Although this approach ensured the highest level of sensitivity in the detection of serious bacterial infection (SBI), such evaluations were time- and labor-intensive, and created a risk for unnecessary adverse reactions to medications.